FDAFDA · Food and drugs·Recall number D-0804-2018
Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01
Published May 9, 2018 · Recall initiated: April 27, 2018
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- DOCETAXEL
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Distributor
- US nationwide
- Lot
- Lot #: 7F307A, 7F307C, Exp 01/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States